IL Pharmaceuticals

Mediwound Ltd (MDWD)

Track

Track

Mediwound Ltd experienced six insider trading transactions recently, resulting in a net selling trend. Executives offloaded shares following the latest earnings report, which showed a slight miss. While some buying activity occurred, total divestments outweighed acquisitions, occurring amidst a 4.4% decline in stock value over the past quarter.
Ticker: MDWD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Mediwound Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
Rubinstein Samuel Non-Executive Director
Transaction date
Purchase
Price
71.95
Quantity 24,798 -31.0%
Value US$3,210,589
2.5
Rubinstein Samuel Non-Executive Director
Transaction date
Sale
Price
282.89
Quantity 42,416 -11.4%
Value US$2,889,026
Hess Shmuel COO & Chief Commercial Officer Officer
Transaction date
Sale
Price
53.42
Quantity 98,869 -16.3%
Value US$602,203
Hess Shmuel COO & Chief Commercial Officer Officer
Transaction date
Sale
Price
12.72
Quantity 1,979 -100.0%
Value US$25,173
Shmulik Hess Officer Officer
Transaction date
Proposed sale
Price
12.70
Quantity 3,958
Value US$50,267
Hess Shmuel COO & Chief Commercial Officer Officer
Transaction date
Sale
Price
13.00
Quantity 1,865 -100.0%
Value US$24,245
1.5
SHAMIR NACHUM Non-Executive Director
Transaction date
Purchase
Price
14.00
Quantity 5,825 +11.7%
Value US$81,550
1.5
SHAMIR NACHUM Non-Executive Director
Transaction date
Purchase
Price
13.98
Quantity 175 +0.4%
Value US$2,446
Fox David Morton Non-Executive Director
Transaction date
Purchase
Price
14.00
Quantity 1,797 +8.8%
Value US$25,149
Fox David Morton Non-Executive Director
Transaction date
Purchase
Price
14.23
Quantity 10 +0.0%
Value US$142
Fox David Morton Non-Executive Director
Transaction date
Purchase
Price
14.23
Quantity 1,730 +9.2%
Value US$24,609
2.5
Rubinstein Samuel Non-Executive Director
Transaction date
Purchase
Price
14.33
Quantity 150 +5.3%
Value US$2,150
Hess Shmuel Officer Officer
Transaction date
Proposed sale
Price
17.21
Quantity 3,693
Value US$63,557
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-02 2026-09-01 B Purchase
2.5
Rubinstein Samuel
Non-Executive Director
24,798 -31.0%
71.95
US$3,210,589 		24,798 -31.0% 71.95 US$3,210,589
2026-09-02 2026-09-01 S Sale
2.5
Rubinstein Samuel
Non-Executive Director
42,416 -11.4%
282.89
US$2,889,026 		42,416 -11.4% 282.89 US$2,889,026
2026-08-28 2026-08-27 S Sale
Hess Shmuel

COO & Chief Commercial Officer

Officer
98,869 -16.3%
53.42
US$602,203 		98,869 -16.3% 53.42 US$602,203
2026-08-28 2026-08-27 S Sale
Hess Shmuel

COO & Chief Commercial Officer

Officer
1,979 -100.0%
12.72
US$25,173 		1,979 -100.0% 12.72 US$25,173
2026-08-28 2026-08-27 PrS Proposed sale
Shmulik Hess

Officer

Officer
3,958
12.70
US$50,267 		3,958 12.70 US$50,267
2026-08-28 2026-08-26 S Sale
Hess Shmuel

COO & Chief Commercial Officer

Officer
1,865 -100.0%
13.00
US$24,245 		1,865 -100.0% 13.00 US$24,245
2026-06-04 2026-06-03 B Purchase
1.5
SHAMIR NACHUM
Non-Executive Director
5,825 +11.7%
14.00
US$81,550 		5,825 +11.7% 14.00 US$81,550
2026-06-04 2026-06-03 B Purchase
1.5
SHAMIR NACHUM
Non-Executive Director
175 +0.4%
13.98
US$2,446 		175 +0.4% 13.98 US$2,446
2026-06-02 2026-06-01 B Purchase
Fox David Morton
Non-Executive Director
1,797 +8.8%
14.00
US$25,149 		1,797 +8.8% 14.00 US$25,149
2026-06-02 2026-06-01 B Purchase
Fox David Morton
Non-Executive Director
10 +0.0%
14.23
US$142 		10 +0.0% 14.23 US$142
2026-06-02 2026-06-01 B Purchase
Fox David Morton
Non-Executive Director
1,730 +9.2%
14.23
US$24,609 		1,730 +9.2% 14.23 US$24,609
2026-06-01 2026-05-29 B Purchase
2.5
Rubinstein Samuel
Non-Executive Director
150 +5.3%
14.33
US$2,150 		150 +5.3% 14.33 US$2,150
2025-12-03 2025-12-02 PrS Proposed sale
Hess Shmuel

Officer

Officer
3,693
17.21
US$63,557 		3,693 17.21 US$63,557
Explore more

More insider trading research around Mediwound Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity